Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events (vol 18, 200193, 2023)

被引：0

作者：

Ikebe, So ^{[1
]}

Ishii, Masanobu ^{[1
]}

Otsuka, Yasuhiro ^{[1
]}

Nakamura, Taishi ^{[1
,2
]}

Tsujita, Kenichi ^{[1
]}

Matoba, Tetsuya ^{[3
]}

Kohro, Takahide ^{[4
]}

Oba, Yusuke ^{[5
]}

Kabutoya, Tomoyuki ^{[5
]}

Imai, Yasushi ^{[6
]}

Kario, Kazuomi ^{[5
]}

Kiyosue, Arihiro ^{[7
]}

Mizuno, Yoshiko ^{[7
,8
]}

Nochioka, Kotaro ^{[9
]}

Nakayama, Masaharu ^{[10
]}

Iwai, Takamasa ^{[11
]}

Miyamoto, Yoshihiro ^{[12
]}

Sato, Hisahiko ^{[13
]}

Akashi, Naoyuki ^{[14
]}

Fujita, Hideo ^{[14
]}

Nagai, Ryozo ^{[15
]}

机构：

[1] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1,Honjo Chuo-ku, Kumamoto 8608556, Japan

[2] Kumamoto Univ, Grad Sch Med Sci, Dept Med Informat Sci, Kumamoto, Japan

[3] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan

[4] Jichi Med Univ, Sch Med, Dept Clin Informat, Tochigi, Japan

[5] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Tochigi, Japan

[6] Jichi Med Univ, Dept Pharmacol, Div Clin Pharmacol, Tochigi, Japan

[7] Univ Tokyo Hosp, Dept Cardiovasc Med, Tokyo, Japan

[8] Dev Bank Japan Inc, Tokyo, Japan

[9] Tohoku Univ Hosp, Div Cardiovasc Med, Sendai, Japan

[10] Tohoku Univ, Grad Sch Med, Dept Med Informat, Miyagi, Japan

[11] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Japan

[12] Natl Cerebral & Cardiovasc Ctr, Open Innovat Ctr, Osaka, Japan

[13] Precision Inc, Tokyo, Japan

[14] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama, Japan

[15] Jichi Med Univ, Sch Med, Tochigi, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION | 2024年 / 22卷

关键词：

D O I：

10.1016/j.ijcrp.2024.200304

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页数：1

共 50 条

[21] Stratification Analysis of Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis
Horikoshi, Takeo
Nakamura, Takamitsu
Yoshizaki, Toru
Nakamura, Jun
Makino, Aritaka
Saito, Yukio
Obata, Jun-ei
Sawanobori, Takao
Takano, Hajime
Umetani, Ken
Watanabe, Akinori
Asakawa, Tetsuya
Kugiyama, Kiyotaka
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 168 - 176
[22] Effect of postmenopausal hormone therapy on major adverse cardiac events after percutaneous coronary intervention: The HERS trial
Khan, MA
Shlipak, MG
Liu, MW
Rogers, WJ
Lin, F
Hlatky, MA
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 56A - 56A
[23] Development and validation of a nomogram for major adverse cardiovascular events after chronic total occlusion percutaneous coronary intervention for ischemic heart failure
Du, Jiaqi
Yang, Lulu
Hao, Zhengyang
Li, Huan
Yang, Chunlei
Wang, Xing
Zhang, Zhaozhi
Du, Youyou
Zhang, Yanzhou
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (03) : 451 - 461
[24] Aetiology and predictors of major bleeding events in patients with heart failure with reduced ejection fraction undergoing percutaneous coronary intervention
Iyer, Meghana
Shah, Rohan
Zheng, Weili
Ziada, Khaled M.
Khot, Umesh
Krishnaswamy, Amar
Kapadia, Samir R.
Reed, Grant W.
OPEN HEART, 2024, 11 (01):
[25] Major Adverse Cardiac Events After Non-cardiac Surgery Following Previous Percutaneous Coronary Intervention With Stent Implantation
Wasowicz, Marcin
Syed, Summer
Starzyk, Lukasz
Wijeysundera, Duminda
Beattie, Scott W.
CIRCULATION, 2014, 130
[26] Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention
Wakabayashi, Yasushi
Wada, Hiroshi
Sakakura, Kenichi
Yamamoto, Kei
Mitsuhashi, Takeshi
Ako, Junya
Momomura, Shin-ichi
JOURNAL OF CARDIOLOGY, 2015, 66 (3-4) : 341 - 346
[27] Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
Deng, Wenqi
Wang, Dayang
Wan, Yandi
Lai, Sijia
Ding, Yukun
Wang, Xian
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
[28] Impact of socioeconomic status on medication compliance and major adverse cardiac events (MACE) following percutaneous coronary intervention (PCI)
Lefkovits, L.
Andrianopoulos, N.
Stub, D.
Clark, D. J.
Ajani, A. E.
Brennan, A. L.
New, G.
Reid, C. M.
Dart, A. M.
Duffy, S. J.
EUROPEAN HEART JOURNAL, 2009, 30 : 848 - 848
[29] The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
Benjamin, Botey Katamu
Qiu, Chunguang
Han, Zhanying
Lu, Wenjie
Sun, Guoju
Qin, Xiaofei
Wang, Xule
Wang, Xi
Li, Ran
Pan, Liang
JOURNAL OF DIABETES RESEARCH, 2021, 2021
[30] Does elevated asymmetrical dimethylarginine predict major adverse cardiac events and mortality in patients after percutaneous coronary intervention?
Shao, Yang
Fan, Yichuan
Li, Jun
Cao, Hui
Liu, Bing
Wang, Junpeng
Yang, Jun
Zhang, Qiang
Hu, Xinhua
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 178 : 188 - 190

← 1 2 3 4 5 →